Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 44Recruiting 36Completed 27Not yet recruiting 16Active not recruiting 10Withdrawn 7Terminated 4Enrolling by invitation 2Suspended 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Carcinoma, Hepatocellular 2Stomach Neoplasms 1Liver Neoplasms 1

Interventions

toripalimab 2lenvatinib 2Tacrolimus 1Surgical Procedures, Operative 1Preoperative Exercise 1Mycophenolic Acid 1Everolimus 1Breathing Exercises 1Bevacizumab 1Azathioprine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Enrolling by invitation × Carcinoma, Hepatocellular × lenvatinib × Clear all
NCT07052448 2025-07-04

The Efficacy of Sequential RT After Triple Therapy for uHCC

Fujian Provincial Hospital

Enrolling by invitation
35 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT05171335 2022-09-21

Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular Carcinoma Patients

The Methodist Hospital Research Institute

Phase 2 Enrolling by invitation
50 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡